InfuSystem Holdings (INFU) Depreciation & Amortization (CF) (2010 - 2026)
InfuSystem Holdings (INFU) posted Depreciation & Amortization (CF) of $3.0 million for Q1 2026, down 3.0% on a QoQ basis from $3.1 million in Q4 2025, and down 0.91% year-over-year from $3.1 million in Q1 2025.
InfuSystem Holdings (INFU) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 0.91% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.3 million (up 3.5% YoY) and the FY2025 annual result came in at $12.4 million, up 7.53% from the prior year.
- Depreciation & Amortization (CF) was $3.0 million for Q1 2026 at InfuSystem Holdings, down from $3.1 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $3.2 million in Q4 2024 and bottomed at $2.7 million in Q1 2024.
- A 5-year average of $2.9 million and a median of $2.9 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) decreased 26.51% — and 2025, when it increased 15.84%.
- InfuSystem Holdings' Depreciation & Amortization (CF) stood at $2.7 million in 2022, then gained by 5.92% to $2.9 million in 2023, then advanced by 9.53% to $3.2 million in 2024, then slipped by 1.1% to $3.1 million in 2025, then decreased by 3.0% to $3.0 million in 2026.
- Business Quant data shows INFU's Depreciation & Amortization (CF) at $3.0 million in Q1 2026, $3.1 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.04 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Dec 31, 2023 | 2.90 Mn |